FANJ
REGN icon

Financial Architects (New Jersey)’s Regeneron Pharmaceuticals REGN Stock Holding History

Financial Architects (New Jersey)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30
Closed -$19K – 650
2020
Q2 		$19K Buy
30
+24
+400% +$13.6K ﹤0.01% 550
2020
Q1 		$3K Buy
+6
New +$2.48K ﹤0.01% 756
2019
Q2 		– Sell
-26
Closed -$11K – 1413
2019
Q1 		$11K Sell
26
-154
-86% -$63.4K ﹤0.01% 1066
2018
Q4 		$67K Hold
180
– – 0.01% 492
2018
Q3 		$73K Sell
180
-100
-36% -$38.1K 0.01% 541
2018
Q2 		$97K Hold
280
– – 0.02% 411
2018
Q1 		$96K Buy
280
+132
+89% +$45.9K 0.02% 464
2017
Q4 		$56K Buy
148
+100
+208% +$40.5K 0.01% 648
2017
Q3 		$21K Sell
48
-29
-38% -$13.8K ﹤0.01% 948
2017
Q2 		$38K Hold
77
– – 0.01% 766
2017
Q1 		$30K Sell
77
-15
-16% -$5.56K 0.01% 826
2016
Q4 		$34K Buy
92
+8
+10% +$3.04K 0.01% 693
2016
Q3 		$34K Buy
84
+56
+200% +$22.5K 0.01% 689
2016
Q2 		$10K Buy
28
+5
+22% +$1.93K ﹤0.01% 983
2016
Q1 		$8K Buy
+23
New +$9.48K ﹤0.01% 807
2013
Q4 		– Sell
-150
Closed -$47K – 459
2013
Q3 		$47K Buy
+150
New +$39.5K 0.03% 256

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Architects (New Jersey)'s REGN Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of Regeneron Pharmaceuticals (REGN) in Q3 2020, closing a stake of 30 shares — an estimated $19K sold.

Financial Architects (New Jersey) first reported a position in REGN in Q3 2013 and held it in 16 quarters. The position peaked at $97K in Q2 2018. 907 funds tracked by Wall St. Rank hold REGN as of Q3 2020.

  • Financial Architects (New Jersey) reported no remaining Regeneron Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 30 Regeneron Pharmaceuticals shares in Q3 2020, an estimated $19K.
  • Financial Architects (New Jersey) first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 16 quarters.
  • Financial Architects (New Jersey)'s Regeneron Pharmaceuticals position peaked at $97K in Q2 2018.
  • 907 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.